VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
CANF
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
CANFCan-Fite BioPharma Ltd.
$1.81$2M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCANFQuarterly Financials

Can-Fite BioPharma Ltd. (CANF) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Can-Fite BioPharma Ltd. (CANF) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

CANF Income Statement

Quarterly statement

CANF Income Statement

Can-Fite BioPharma Ltd. (CANF) annual income statement — 15-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Sales/Revenue101K101K101.5K101.5K101K101K179K179K158K158K155K196K196K196K197K204K204K205K204K251K
Revenue Growth %0%0%-43.3%-43.3%-36.08%-36.08%15.48%-8.67%-19.39%-19.39%-21.32%-3.92%-3.92%-4.39%-3.43%-18.73%-18.4%38.51%36%18.96%
Cost of Goods Sold00000000000000000000
COGS % of Revenue--------------------
Gross Profit101K101K101.5K101.5K101K101K179K179K158K158K155K196K196K196K197K204K204K205K204K251K
Gross Margin %100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%
Gross Profit Growth %0%0%-43.3%-43.3%-36.08%-36.08%15.48%-8.67%-19.39%-19.39%-21.32%-3.92%-3.92%-4.39%-3.43%-18.73%-18.4%38.51%36%18.96%
Operating Expenses2.44M2.44M2.63M2.63M2.55M2.55M2.2M2.2M2.21M2.21M1.99M2.06M1.98M2.91M3.28M2.78M2.27M2.58M4.23M3.76M
OpEx % of Revenue2416.83%2416.83%2588.67%2588.67%2524.75%2524.75%1227.37%1227.37%1395.57%1395.57%1283.23%1051.53%1010.2%1483.67%1664.97%1361.27%1114.71%1256.1%2074.51%1498.41%
Selling, General & Admin713K713K798K798K1.03M1.03M761K761K762.5K762.5K722K762K624K847K826K741K822K754K1.13M822K
SG&A % of Revenue705.94%705.94%786.21%786.21%1022.77%1022.77%425.14%425.14%482.59%482.59%465.81%388.78%318.37%432.14%419.29%363.24%402.94%367.8%554.41%327.49%
Research & Development1.73M1.73M1.83M1.83M1.52M1.52M1.44M1.44M1.44M1.44M1.27M1.3M1.36M2.06M2.45M2.04M1.45M1.82M3.1M2.94M
R&D % of Revenue1710.89%1710.89%1802.46%1802.46%1501.98%1501.98%802.23%802.23%912.97%912.97%817.42%662.76%691.84%1051.53%1245.69%998.04%711.76%888.29%1520.1%1170.92%
Other Operating Expenses00000000000000000000
Operating Income-2.34M-2.34M-2.53M-2.53M-2.45M-2.45M-2.02M-2.02M-2.05M-2.05M-1.83M-1.86M-1.78M-2.71M-3.08M-2.57M-2.07M-2.5M-4.03M-3.51M
Operating Margin %-2316.83%-2316.83%-2488.67%-2488.67%-2424.75%-2424.75%-1127.37%-1127.37%-1295.57%-1295.57%-1183.23%-951.53%-910.2%-1383.67%-1564.97%-1261.27%-1014.71%-1218.54%-1974.51%-1398.41%
Operating Income Growth %4.45%4.45%-25.17%-25.17%-19.64%-19.64%-10.03%-8.2%-14.74%24.52%40.51%27.52%13.82%-8.57%23.46%26.7%33.93%-15.06%-13.37%-41.59%
EBITDA-2.34M-2.34M-2.53M-2.53M-2.44M-2.44M-2.02M-2.02M-2.05M-2.05M-1.83M-1.86M-1.78M-2.71M-3.08M-2.57M-2.07M-2.49M-4.02M-3.51M
EBITDA Margin %-2316.34%-2316.34%-2488.18%-2488.18%-2413.37%-2413.37%-1125.7%-1125.7%-1295.25%-1295.25%-1180.81%-949.74%-908.16%-1381.89%-1563.2%-1259.56%-1013.24%-1216.83%-1972.79%-1397.21%
EBITDA Growth %4.02%4.02%-25.34%-25.34%-19.11%-19.11%-10.09%-8.25%-14.97%24.44%40.57%27.55%13.88%-8.58%23.48%26.73%33.94%-15.06%-13.37%-41.67%
D&A (Non-Cash Add-back)50050050050011.5K11.5K3K3K5005003.75K3.5K4K3.5K3.5K3.5K3K3.5K3.5K3K
EBIT-2.34M-2.34M-2.53M-2.53M-2.45M-2.45M-2.02M-2.02M-2.05M-2.05M-1.83M-1.86M-1.78M-2.71M-3.08M-2.57M-2.07M-2.37M-4.03M-3.51M
Net Interest Income39.5K39.5K131K131K11K11K77K77K68.5K68.5K113K103K111K162K347K44K-121K-64K-315K110K
Interest Income000011K11K77K77K68.5K68.5K127K106K111K162K363K44K000110K
Interest Expense000000000014K3K0016K0121K64K315K0
Other Income/Expense39.5K39.5K50K50K11K11K56.5K56.5K68.5K68.5K182K103K114K162K64K44K-121K-64K-90K110K
Pretax Income-2.3M-2.3M-2.48M-2.48M-2.44M-2.44M-1.96M-1.96M-1.98M-1.98M-1.65M-1.76M-1.67M-2.55M-3.02M-2.53M-2.19M-2.43M-4.12M-3.4M
Pretax Margin %-2277.72%-2277.72%-2439.41%-2439.41%-2413.86%-2413.86%-1095.81%-1095.81%-1252.22%-1252.22%-1065.81%-898.98%-852.04%-1301.02%-1532.49%-1239.71%-1074.02%-1187.32%-2018.63%-1354.58%
Income Tax00000000000-3.5K-4K-162K-64K-88K242K128K0-3K
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0.2%0.24%6.35%2.12%3.48%-11.05%-5.26%0%0.09%
Net Income-2.3M-2.3M-2.48M-2.48M-2.44M-2.44M-1.96M-1.96M-1.98M-1.98M-1.65M-1.76M-1.67M-2.39M-2.96M-2.44M-2.43M-2.56M-4.12M-3.4M
Net Margin %-2277.72%-2277.72%-2439.41%-2439.41%-2413.86%-2413.86%-1095.81%-1095.81%-1252.22%-1252.22%-1065.81%-898.98%-852.04%-1218.37%-1500%-1196.57%-1192.65%-1249.76%-2018.63%-1354.58%
Net Income Growth %5.64%5.64%-26.23%-26.23%-23.22%-23.22%-18.73%-11.32%-18.47%17.15%44.09%27.82%31.36%6.79%28.24%28.21%24.42%-36.42%-13.35%-32.04%
Net Income (Continuing)-2.3M-2.3M-2.48M-2.48M-2.44M-2.44M-1.96M-1.96M-1.98M-1.98M-1.65M-1.76M-1.67M-2.55M-3.02M-2.53M-2.19M-2.43M-4.12M-3.4M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.62-0.62-0.01-1.14-0.21-0.21-0.24-0.24-0.33-0.33-0.33-0.42-0.42-0.66-1.11-0.93-0.81-0.90-3.03-1.86
EPS Growth %-195.24%-195.24%96.83%-375%36.36%36.36%27.27%42.86%21.43%50%70.27%54.84%48.15%26.67%63.37%50%56.45%23.08%-29.49%-10.71%
EPS (Basic)-0.62-0.62-0.01-1.14-0.21-0.21-0.24-0.24-0.33-0.33-0.33-0.42-0.42-0.66-1.11-0.93-0.81-0.90-3.03-1.86
Diluted Shares Outstanding3.71M3.71M323.27M2.16M11.37M11.37M8.44M8.44M6.07M6.07M4.95M4.08M4.08M3.93M2.72M2.72M2.72M2.72M2.22M1.83M
Basic Shares Outstanding3.71M3.71M323.27M2.16M11.38M11.38M8.44M8.44M6.07M6.07M4.95M4.08M4.09M3.93M2.72M2.72M2.72M2.72M1.36M1.83M
Dividend Payout Ratio--------------------